维普期刊资源整合服务平台（V6.5）

83篇 您的检索式：作者名="Isakoff"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Phase II trial of biealu- tamide in patients with androgen receptor-positive, estrogen re- ceptor-negative metastatic Breast Cancer 显示文摘	Guealp A Tolaney S Isakoff SJ	2013	Clin Cancer Res2013，19，19：	1
2	Stand up to cancer phase Ib study of pan - phosphoinositide - 3 - kinase inhibitor buparlisib with letrozole in estrogen receptor - positive/human epidermal growth factor receptor 2 - negative metastatic breast cancer显示文摘	Mayer IA Abramson VG Isakoff SJ	2014	J Clin Oncol2014，32，12：	1
3	Poor survival for os- teosarcoma of the pelvis: a report from the Children's Oncolo- gy Group 显示文摘	Isakoff MS Barkauskas DA Ebb D	2012	Clin Orthop Relat Res2012，470，7：	1
4	A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen显示文摘	Xiao-Jun Ma Zuncai Wang Paula D Ryan Steven J Isakoff Anne Barmettler Andrew Fuller Beth Muir Gayatry Mohapatra Ranelle Salunga J.Todd Tuggle Yen Tran Diem Tran Ana Tassin Paul Amon Wilson Wang Wei Wang Edward Enright Kimberly Stecker Eden Estepa-Sabal Ba	2004	Cancer Cell2004，，6：	1
5	The response of parotid he- mangiomas to the use of systemic interferon alpha-2a or corticosteroids 显示文摘	Blei F Isakoff M Deb G	1997	Arch Otolaryngol Head Neck Surg1997，123，8：	1
6	The B cell SH2/PH domain-containing adapter Bam32/DAPPI is required for T cell-independent Ⅱ antigen responses显示文摘	Fournier E Isakoff SJ Ko K	2003	Car Biol2003，13，：	1
7	Breast cancer associated PIK3CA mutations are oncogenic in mammary epithelial cells显示文摘	Isakoff SJ Engelman JA Irie HY		0，，23：	1
8	Osteosarcoma: Current treatment and a collaborative pathway to success 显示文摘	Isakoff MS Bielack SS Meltzer P	2015	J Clin On- col2015，33，27：	1
9	Bladder/prostate rhabdomyosarcoma: past, present and future显示文摘	Ferrer FA Isakoff M Koyle MA	2006	J Urol2006，176，41：	1
10	Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic Breast Cancer显示文摘	Gucalp A Tolaney S Isakoff SJ	2013	Clin Cancer Re2013，19，19：	1
11	Bladder/prostate rhabdomyosarcoma: past, present and future显示文摘	Fetter FA Isakoff M Koyle MA	2006	J Urol2006，176，41：	1
12	The response of parotid hemangiomas to the use of systemic interferon alfa-2a or corticosteroids 显示文摘	Blei F Isakoff M Deb G	1997	Arch Otolaryngol Head Neck Surg1997，123，8：	1
13	Increased risk of symptomatic haemangiomas of the airway in association with cutaneous haemangiomas in a dbeardT distribution 显示文摘	Orlow SJ Isakoff MS BM F	1997	J Pediatr1997，131，：	1
14	Osteosarcoma: current treatment anda collaborative pathway to success显示文摘	Isakoff MS Bielack SS Meltzer P	2015	J Clin Oncol2015，33，27：	1
15	Phase II trial of bicalu- tamide in patients with androgen receptor-positive, estrogen re- ceptor-negative metastatic Breast Cancer 显示文摘	Gucalp A Tolaney S Isakoff SJ	2013	Clin Cancer Res2013，19，19：	1
16	Triple-negative breast cancer: role of specific chemo- therapy agents显示文摘	Isakoff SJ	2010	Cancer J2010，16，1：	1
17	Bladder/prostate rhabdomyosarcoma: past, present and future显示文摘	Ferrer F A Isakoff M Koyle M A	2006	J Urol2006，176，41：	1
18	Breast cancer-associated PIK3CA mutations are oncogenic in mammary epithelial cells 显示文摘	Isakoff SJ Engelman JA Irie HY	2005	Cancer Res2005，65，10：	1
19	Trastuzumab-DM1 : building a chemotherapy-free road in the treatment of human epidermal growth factor receptor 2- positive breast cancer 显示文摘	Isakoff SJ Baselga J	2011	J Clin Oncol2011，29，4：	1
20	TBCRC009 : a Multicenter phase I clinical trial of platinum monotherapy with biomarker assessment in metastatic triple-negative breast cancer显示文摘	Isakoff SJ Mayer EL He L et al	2015	J Clin Oncol2015，33，17：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示